Back to competency map

Clinical competency

Support patients with moderate-to-severe major depressive disorder

Therapists/facilitators require knowledge of treating patients with moderate-to-severe major depressive disorder in the context of psychedelic-assisted therapy. The target population in the trial establishes disorder-specific clinical knowledge needs.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

2

Courses

0

Providers

0

Protocols

2

Classification

Care stages

Cross-phase

Protocol families

DMT / AyahuascaLSD

Source quality

Protocol paperTrial supplement

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (2)

  • Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

    DMT / AyahuascaEvidence score: 100
    de Almeida et al., 2015Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth
Support patients with moderate-to-severe major depressive disorder - Clinical Competency | Blossom